Michael M. Gottlieb - 06 Jul 2021 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role
Chief Commercial Officer
Signature
/s/ William L. Demers, by Power of Attorney for Michael M. Gottlieb
Issuer symbol
PNT
Transactions as of
06 Jul 2021
Transactions value $
$0
Form type
4
Filing time
08 Jul 2021, 16:34:08 UTC
Previous filing
30 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +48K $0.00 48K 06 Jul 2021 Common Stock 48K $8.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on July 6, 2022 with the remaining 75% vesting in three equal annual installments thereafter.